Australian COVID-19 vaccine shows promising results in animal trials

By: |
August 26, 2020 3:55 PM

The researchers noted that one of the big challenges in the development of vaccines is the ability to produce them at sufficient scale for widespread use.

Phase 1 study being conducted in Queensland is progressing well.Phase 1 study being conducted in Queensland is progressing well.

A COVID-19 vaccine candidate being developed by Australia’s University of Queensland has shown “positive” results against the novel coronavirus in preclinical tests, raising hopes for its potential effectiveness and manufacturability, the varsity said on Wednesday.

According to the yet-to-be published findings, the vaccine combined with the Seqirus MF59 adjuvant, provided protection against virus reproduction in hamster models, and reduced lung inflammation, following exposure to the virus.

Associate Professor Keith Chappell, who is the project co-leader, has reported to the International Society for Vaccines on the data from animal trials conducted by Viroclinics-DDL in the Netherlands, according to a statement.

“The neutralising immune response created by our molecular clamp vaccine in animal models was better than the average level of antibodies found in patients who have recovered from COVID-19,” Chappell said.

“It also induces a strong T-cell response and showed strong results when it came to data relating to manufacturability,” he said.

The researchers noted that one of the big challenges in the development of vaccines is the ability to produce them at sufficient scale for widespread use.

They said the phase 1 study being conducted in Queensland is progressing well and assuming the study demonstrates adequate safety and immune responses, data should be available in time to commence the required large-scale efficacy study before the end of the year.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1India may soon allow Covid-19 jab for pregnant women, but where are the vaccine stocks?
2Covid-19: West Bengal reports highest single-day spike of 20,839 cases, 129 deaths
3Equipped with 6.48 lakh Covid jabs, Jharkhand to start free vaccination for 18-44 age group from tomorrow